US Congress House Bill 6092 (Prior Session Legislation)

---

Spectrum: Slight Partisan Bill (Republican 3-1)
Status: Engrossed on September 23 2020 - 50% progression, died in committee
Action: 2020-09-23 - Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
Pending: Senate Veterans' Affairs Committee
Text: Latest bill text (Engrossed) [PDF]

Requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer. Specifically, the bill requires the VA to establish in its National Surgery Office a national clinical pathway for all stages of prostate cancer that includes specified elements. A clinical pathway is a health care management tool designed around research and evidence-backed practices that provides direction for the clinical care and treatment of a specific episode of a condition or ailment. The VA must publish the proposed clinical pathway in the Federal Register for public comment. Additionally, the bill requires the VA to publish the established clinical pathway on a public VA website and to update the clinical pathway at least annually. Under the bill, the VA must submit (1) a plan to establish a comprehensive prostate cancer program, and (2) a plan that provides for continual funding for supporting prostate cancer research through the VA Office of Research and Development. The VA must also establish a program evaluation tool to learn best practices of multidisciplinary disease-based implementation. Finally, the VA must establish a real-time, actionable, national prostate cancer registry that is accessible to clinicians and researchers.

Veteran's Prostate Cancer Treatment and Research Act

Rep. Neal Dunn [R-FL]

Rep. Joe Cunningham [D-SC]

Rep. Greg Murphy [R-NC]

Rep. Jeff Van Drew [R-NJ]

Date	Chamber	Action
2020-09-23	Senate	Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
2020-09-22	House	Motion to reconsider laid on the table Agreed to without objection.
2020-09-22	House	On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4684-4685)
2020-09-22	House	DEBATE - The House proceeded with forty minutes of debate on H.R. 6092.
2020-09-22	House	Considered under suspension of the rules. (consideration: CR H4682-4685)
2020-09-22	House	Mr. Takano moved to suspend the rules and pass the bill, as amended.
2020-09-17	House	Ordered to be Reported by Voice Vote.
2020-09-17	House	Committee Consideration and Mark-up Session Held.
2020-09-10	House	Committee Hearings Held.
2020-03-05	House	Referred to the House Committee on Veterans' Affairs.
2020-03-05	House	Introduced in House

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/house-bill/6092/all-info
Text	https://www.congress.gov/116/bills/hr6092/BILLS-116hr6092ih.pdf
Text	https://www.congress.gov/116/bills/hr6092/BILLS-116hr6092eh.pdf